SAB Biotherapeutics
SABS
SABS
25 hedge funds and large institutions have $10.1M invested in SAB Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
RI
1
RTW Investments
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$112K |
| 3 |
3
First Manhattan
New York
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$3.2K |
